Arthur Tzianabos

Arthur Tzianabos

Net worth: 1 M $ as of 2026-08-30

63 year
Health Technology
Consumer Services
Finance

Profile

Dr. Arthur O.
Tzianabos
is a Venture Partner at 5AM Venture Management LLC, an Executive Chairman at Stoke Therapeutics, Inc., a Member-Development Board at University of New Hampshire and a President & Chief Executive Officer at Lifordi Immunotherapeutics, Inc. He is on the Board of Directors at Alliance for Regenerative Medicine, Q32 Bio, Inc. and Oxford Biomedica Solutions LLC.
Dr. Tzianabos was previously employed as a Chairman by Akouos, Inc., a Chairman by Homology Medicines, Inc., a President & Chief Scientific Officer by OvaScience, Inc., a Senior VP, Head-Research & Early Development by Shire Plc, an Associate Professor & Member by Harvard Medical School, and a Senior VP, Head-Research & Early Development by Shire Pharmaceuticals, Inc. He also served on the board at DNIB Unwind, Inc. and ArmaGen, Inc. He received his undergraduate degree from Boston College and a doctorate degree from the University of New Hampshire.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-02 31,339 ( 0.05% ) 977 777 $ 2026-08-30
0.03%
2026-06-11 7,983 ( 0.03% ) 118 707 $ 2026-08-30

Arthur Tzianabos active positions

CompaniesPositionStart
STOKE THERAPEUTICS, INC. Chairman 2023-12-31
Private Equity Investor 2022-08-31
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member 2018-10-02

Former positions of Arthur Tzianabos

CompaniesPositionEnd
AKOUOS Chairman 2022-11-30
DNIB UNWIND INC Director/Board Member 2016-07-26
President 2016-03-30
SHIRE Chief Tech/Sci/R&D Officer 2013-08-31
░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Arthur Tzianabos's experience

Training of Arthur Tzianabos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

92

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

Producer Manufacturing

  1. Stock Market
  2. Insiders
  3. Arthur Tzianabos